FundX Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

FundX Investment Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,516	Closed	-$1.71M	–	36
2020 Q2	$1.71M	Buy	+12,516	New	+$1.6M	0.72%	24
2015 Q4	–	Sell	-124,143	Closed	-$12.6M	–	23
2015 Q3	$12.6M	Buy	124,143 +12,099	+11%	+$1.45M	6.17%	6
2015 Q2	$13.8M	Buy	112,044 +2,028	+2%	+$243K	5.71%	8
2015 Q1	$12.6M	Buy	110,016 +2,337	+2%	+$258K	3.89%	9
2014 Q4	$10.9M	Buy	+107,679	New	+$10.5M	3.27%	11
2014 Q2	–	Sell	-235,476	Closed	-$18.6M	–	20
2014 Q1	$18.6M	Buy	235,476 +3,435	+1%	+$286K	7.8%	4
2013 Q4	$17.6M	Sell	232,041 -12,546	-5%	-$890K	7.79%	4
2013 Q3	$17.1M	Buy	244,587 +13,596	+6%	+$891K	6.76%	4
2013 Q2	$13.4M	Buy	+230,991	New	+$13.4M	5.72%	6

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

FundX Investment Group's IBB Position: Q3 2020 in Review

FundX Investment Group sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 12,516 shares — an estimated $1.71M sold.

FundX Investment Group first reported a position in IBB in Q2 2013 and held it in 9 quarters. The position peaked at $18.6M in Q1 2014. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

FundX Investment Group reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
FundX Investment Group sold 12,516 iShares Biotechnology ETF shares in Q3 2020, an estimated $1.71M.
FundX Investment Group first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 9 quarters.
FundX Investment Group's iShares Biotechnology ETF position peaked at $18.6M in Q1 2014.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on FundX Investment Group's 13F filing for Q3 2020, filed 29 Oct 2020.